The Impact of mHealth on Real-World Data Collection

Real-World Data (RWD) collected via mobile devices creates a larger base of real-world evidence (RWE) for pharma to inform decisions about the cost effectiveness and patient value of a new product to the healthcare system. This article, authored by ERT’s Tim Davis, reviews how pharmaceutical developers can leverage this technology for positive results in the development and accessibility of new treatments, ultimately improving people’s health.

Click here to read the full article.

Share